Other CIBMTR presentations will include additional results from ACCESS study; a trial in progress update on the ACCELERATE trial (NCT06859424), a platform protocol for testing multiple PTCy-based ...

An update from Seres Therapeutics ( ($MCRB) ) is now available. On November 5, 2025, Seres Therapeutics reported its third-quarter financial ...

For kids with the condition, day-to-day activities like going to school or playing with friends can lead to life-threatening ...

Cynata Therapeutics Limited ( (AU:CYP) ) has issued an announcement. Cynata Therapeutics Limited announced it received a $1.7 million R&D Tax Incentive Refund for the 2024/2025 financial year. This ...

When it comes to the gay community, I talk to men, especially submissive bottoms, about the importance of getting checked," ...

How AI, robotics, and precision medicine are transforming cancer care—bridging hope, technology, and humanity in the ongoing ...

Rachel Uchitel is sparing no expense ahead of her upcoming wedding to Florida security CEO Dan Donovan. Uchitel, 50, who shot ...

Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase compelling results in multiple acute leukemia subtypes across the R/R, frontline, and post-HSCT setting – ...

Q25 – – $32.0 million Revuforj® (revumenib) net revenue; total Revuforj prescriptions in 3Q25 increased 25% over 2Q25, highlighting strong demand – – $45.8 million Niktimvo™ (axatilimab-csfr) net ...

The connoisseur of low culture delivers a legal drama with little law but plenty of go-for-broke performances.

Losing one’s hair is common. It is not only psychologically debilitating, but it can have a major effect on self-esteem. It’s ...

This article explores how advances in automation, 3D cell models and AI are transforming high-throughput screening, driving ...